SCHEMBL2551583

SCHEMBL2551583

O=C(CN1CCOCC1)Nc1nc2ccc(SSc3ccc4nc(NC(=O)CN5CCOCC5)sc4c3)cc2s1

nearest known ligand 0.75

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.75
CLK1 P49759 4/20 0.75
HTT P42858 2/20 0.75
KMT2A Q03164 2/20 0.75
MAPT P10636 2/20 0.75
POLB P06746 2/20 0.75
SMN1; SMN2 Q16637 1/20 0.75
MEN1 O00255 1/20 0.75
AHR P35869 1/20 0.70
KDM4E B2RXH2 2/20 0.52
TSHR P16473 2/20 0.52
MET P08581 1/20 0.52
CYP3A4 P08684 1/20 0.52
NPC1 O15118 1/20 0.52
RAB9A P51151 1/20 0.52
PIK3CA P42336 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28643433 0.86 CLK1 (1.00) ALDH1A1CLK1HTTKMT2AMAPT
SCHEMBL11254906 0.85 ALDH1A1 (0.75) ALDH1A1CLK1HTTKMT2AMAPT
SCHEMBL2555063 0.81 MET (0.63) ALDH1A1CLK1HTTKMT2AMAPT
SCHEMBL2542595 0.81 ALDH1A1 (0.57) ALDH1A1CLK1HTTKMT2AMAPT
SCHEMBL3137839 0.79 PIK3CA (0.82) ALDH1A1CLK1HTTKMT2AMAPT
SCHEMBL2576731 0.79 MET (0.65) ALDH1A1CLK1HTTKMT2AMAPT
Fluoride SCHEMBL24503906 0.78 KMT2A (0.70) ALDH1A1CLK1HTTKMT2AMAPT
SCHEMBL2763569 0.78 MET (0.59) ALDH1A1CLK1HTTKMT2AMAPT
SCHEMBL2554477 0.76 MET (0.62) ALDH1A1CLK1HTTKMT2AMAPT
SCHEMBL612904 0.76 MET (0.64) ALDH1A1CLK1HTTKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011121223-A1 6-(ALKYL- OR CYCLOALKYL-TRIAZOLOPYRIDAZINE-SULFANYL) BENZOTHIAZOLE DERIVATIVES: PREPARATION, APPLICATION AS MEDICAMENTS AND USE AS MET INHIBITORS SANOFI-AVENTIS (FR) 2011-10-06 WO disclosed